MLN518

A substance being studied in the treatment of some types of cancer. It may stop cancer cell growth by blocking certain enzymes. It may also prevent the growth of new blood vessels that tumors need to grow. It is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called CT53518 and tandutinib. (NCI Dictionary)

YOU MAY ALSO LIKE

MLN51 Protein

Encoded by human MLN51 Gene, ubiquitous cytoplasmic 76.3 kD MLN51 Protein contains 703 residues that share no significant homology with any known…

MLN2704

A substance that is being studied in the treatment of prostate cancer. It belongs to the family of drugs called antibody drug…

MLN1202

A substance being studied as a treatment for atherosclerosis (a build-up of fat in the arteries). It is also being studied in…

MLLT6 wt Allele

Human MLLT6 wild-type allele is located in the vicinity of 17q21 and is approximately 22 kb in length. This allele, which encodes…

MLLT6 Gene

This gene is involved in transcriptional regulation and aberrations in the gene are associated with acute leukemias due to chromosomal translocations. …

MLLT4 wt Allele

Human MLLT4 wild-type allele is located in the vicinity of 6q27 and is approximately 145 kb in length. This allele, which encodes…